Suneva Medical develops and manufactures regenerative aesthetics products. It also recently announced a SPAC merger agreement with Viveon Health Acquisition Corp. which is expected to be completed in the first half of 2022. Pat Altavilla, CEO of Suneva Medical, joins Nicole Petallides, to discuss the merger and how Suneva Medical will trade on the NYSE under the ticker “RNEW.” She also talks about the growth outlook for the regenerative aesthetics market. Tune in to find out more.
Trading 360
12 Jan 2022
SHARE
The Watch List
03 Nov 2022
Morning Trade Live
01 Nov 2022
The Watch List
01 Nov 2022
Trading 360
13 Oct 2022
The Watch List
27 Oct 2022
Trading 360
29 Nov 2022